MolNFT v1 · #456257 · protein
AlphaFold monomer V2.0 prediction for tryptophan 2,3-dioxygenase (B2SM13)
B2SM13: “AlphaFold monomer V2.0 prediction for tryptophan 2,3-dioxygenase (B2SM13)”. 1 pocket (best druggability 0.77). MolNFT v1 #456257 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- Accession
- B2SM13
- Type
- protein
- Length
- 297 residues
- Chains
- 1
- Collection
- MolNFT v1 / AlphaFold
- Contract
- 0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
- Owner
- 0xbb2F1C7CB3A1eeFAc24fCa72cc627162D5413FD7
- Molecule
- Tryptophan 2,3-dioxygenase
- UniProt
- B2SM13
- Pockets
- 1 · best druggability 0.77
Structure
1 distinct chain · 60% helix, 0% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Tryptophan 2,3-dioxygenase | protein | 297 | 60% helix, 0% strand | B2SM13 |
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 615 | 0.77 | 0.83 | 57 | empty |
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt B2SM13
- Elsewhere: UniProt B2SM13 · AlphaFold DB B2SM13
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.